German family-owned drugmaker Grünenthal, a global leader in pain management and research, has published 2025 financial ...
German family-owned pharma major Boehringer Ingelheim today reported financial results, showing that group sales rose by 7.3% ...
San Diego, USA-based late-stage biotech ADARx Pharmaceuticals announced the appointment of Ryan Fisk as chief financial officer and chief business officer. In this role, he will be responsible for ...
Japan still matters to specialty drug makers for a simple reason: it has a large and fast-aging patient population, broad public insurance and one of the world’s biggest pharmaceutical markets. That ...
Singapore-based biotech Prestige Biopharma has reported positive Phase III results for its Avastin (bevacizumab) biosimilar ...
The US Food and Drug Administration is requiring new label warnings for widely used Parkinson’s therapies combining levodopa ...
US precision medicine company Tempus AI has entered a strategic collaboration with Japanese drugmaker Daiichi Sankyo.
Progressive pulmonary fibrosis (PPF) describes a phenotype of non-idiopathic pulmonary fibrosis (IPF) interstitial lung ...
Japanese drugmaker Ono Pharmaceutical announced it has submitted an application for the manufacturing and marketing approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results